CRIS
CURIS INC
NASDAQ · Healthcare · Biotechnology · US
$1.20
+68.09%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 68.73x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.88x
- Price / sales
- 5.31x
- Price / cash flow
- -0.75x
Enterprise value
- Enterprise value
- $18.3M
- EV / sales
- 4.25x
- EV / EBITDA
- -0.84x
- EV / EBIT
- -0.51x
- Market cap
- $22.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026